WO2011080721A2 - A herbal composition as hepatoprotective and treatment for liver disorders - Google Patents

A herbal composition as hepatoprotective and treatment for liver disorders Download PDF

Info

Publication number
WO2011080721A2
WO2011080721A2 PCT/IB2011/000002 IB2011000002W WO2011080721A2 WO 2011080721 A2 WO2011080721 A2 WO 2011080721A2 IB 2011000002 W IB2011000002 W IB 2011000002W WO 2011080721 A2 WO2011080721 A2 WO 2011080721A2
Authority
WO
WIPO (PCT)
Prior art keywords
extracts
herbal composition
extract
water
fumaria
Prior art date
Application number
PCT/IB2011/000002
Other languages
French (fr)
Other versions
WO2011080721A3 (en
Inventor
Rangesh Paramesh
Uddagiri Venkanna Babu
Ekta Saxena
Original Assignee
Himalaya Global Holdings Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Himalaya Global Holdings Ltd. filed Critical Himalaya Global Holdings Ltd.
Publication of WO2011080721A2 publication Critical patent/WO2011080721A2/en
Publication of WO2011080721A3 publication Critical patent/WO2011080721A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/19Acanthaceae (Acanthus family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/50Fumariaceae (Fumitory family), e.g. bleeding heart

Definitions

  • This invention relates to a herbal composition having hepatoprotective activity. More particularly, the invention relates to a composition comprising extracts of Eclipta prostrata whole parts and/or Cichorium intybus seeds and/or Andrographis paniculata whole parts and/or Fumaria indica whole parts and/or Oroxylum indicum leaves and/or Ailanthus excelsa leaves and a pharmaceutically acceptable carrier, methods of obtaining the same, pharmaceutical formulations thereof and methods of using the composition as hepatoprotective which is useful in treating liver disorders such as jaundice, cirrhosis, non-alcoholic fatty liver disease etc. and other liver disorders due to infection and chemotherapy in humans using said natural herbal composition.
  • the herbal compositions are very effective in curing such diseases in a very efficient manner without any side effects.
  • the herbal composition prepared for liver helps in restoring the metabolic efficiency of the liver by protecting the hepatic parenchyma and promoting hepatocellular regeneration. It also helps in preventing the loss of functional integrity of the cell membrane and in restoring the hepatic function in infective hepatitis.
  • This invention relates to herbal composition which is useful in treating liver disorders such as jaundice, cirrhosis, non-alcoholic fatty liver disease etc. and other liver disorders. More particularly, the invention relates to a herbal composition comprising extracts of Eclipta prostrate whole parts and/or Cichorium intybus seeds and/or Andrographis paniculata whole parts and/or Fumaria indica whole parts and/or Oroxylum indicum leaves and/or Ailanthus excelsa leaves and a pharmaceutically acceptable carrier, methods of obtaining the same, pharmaceutical formulations thereof and methods of using the composition as hepatoprotective agent.
  • the present invention relates to the selection and identification of the herbs and obtaining the extract by subjecting the same to different extraction techniques including conventional solvent extraction and super critical fluid extraction.
  • FIG.l depicts the effect of N P-042/ERNP variants on SGPT level of rats in an experimental model of carbon tetrachloride-induced hepatic damage in rats.
  • FIG.2 depicts the effect of N P-042/ERN P variants on SGOT level of
  • FIG.3 depicts the effect of N P-042/ERNP variants on liver glycogen content of rats in an experimental model of carbon tetrachloride-induced hepatic damage in rats.
  • FIG.5 depicts the comparative evaluation of NP-42 variants for Hepatoprotective activity in an experimental model of thioacetamide induced hepatic damage in rats.
  • FIG.6 depicts the comparative evaluation of NP-42 variants for Hepatoprotective activity in an experimental model of thioacetamide induced hepatic damage in rats.
  • FIG.7 depicts the comparative evaluation of NP-42 variants in an experimental model of carbon tetrachloride -induced hepatic damage in rats.
  • FIG.8 depicts the comparative evaluation of N P-42 variants in an experimental model of carbon tetrachloride induced hepatic damage in rats.
  • FIG.9 depicts the comparative evaluation of NP-42 variants in an experimental model of carbon tetrachloride induced hepatic damage in rats.
  • a herbal composition having hepatoprotective activity comprises effective amounts of extracts of Eclipta prostrato, Cichorium intybus, Andrographis paniculata, Fumaria indica, Ailanthus excelsa and suitable pharmaceutically acceptable carriers and additives.
  • the herbal extracts are obtained either by separate extraction or from the blend of Eclipta prostrata, Cichorium intybus, Andrographis paniculata, Fumaria indica, Ailanthus excelsa parts.
  • the herbal extracts are obtained from the specific parts of the herbs preferably whole parts of Eclipta prostrata, seeds of Cichorium intybus, whole parts of Andrographis paniculata, whole parts of Fumaria indica and leaves of Ailanthus excelsa.
  • the blend of herbs comprises whole parts of Eclipta prostrata, seeds of Cichorium intybus, whole parts of Andrographis paniculata, whole parts of Fumaria indica and leaves of Ailanthus excelsa in the ratio of 20:18:30: 15 :17 respectively.
  • a herbal composition having hepato- protective activity comprises effective amounts of extracts of Eclipta prostrata, Cichorium intybus, Andrographis paniculata, Fumaria indica, Oxoxylum indicum and suitable pharmaceutically acceptable carrier and additives.
  • the herbal extracts are obtained either by separate extraction or from the blend of Eclipta prostrata, Cichorium intybus, Andrographis paniculata, Fumaria indica, Oxoxylum indicum parts.
  • the herbal extracts are obtained from the specific pa rts of the herbs preferably whole parts of Eclipta prostrata, seeds of Cichorium intybus, whole parts of Andrographis paniculata, whole parts of Fumaria indica and leaves of Oxoxylum indicum.
  • the blend of herbs comprises whole parts of Eclipta prostrota, seeds of Cichorium intybus, whole parts of Andrographis paniculata, whole parts of Fumaria indica and leaves of Oxoxylum indicum in the ratio of 20:18:30:15:17 respectively.
  • the extracts are obtained by method selected from the group of percolation method, hot - soxlation method, super - critical - fluid method or enzyme extraction method.
  • the said extracts are obtained by percolation method comprising the following steps of: . a. Shade drying the material; b. Pulverizing the material obtained in step a. to coarse powder; c. Placing the powdered material in different percolators and extracting with n-hexane, acetone, ethyl alcohol, methanol, ethyl alcohol and water (1:1), methanol and water (1:1) and water at room temperature for 24 h to 48 h.; and d. Filtering the plant extracts and concentrating to dryness using a rotatory evaporator or on steam bath at optimum temperature under reduced pressure.
  • the said extracts are obtained by super - critical - fluid extraction method comprising the steps of: a. Shade drying the material; b. Pulverizing the dried material to coarse powder; c. Placing the material in a SCF extractor at the temperature ranging from 40-50 °C at high pressure range of 300-350 bar using carbon dioxide as super critical fluid for extraction upto 4 to 6 hours; and d. Collecting the extract in the collection vessel and evaporating at room temperature to remove any further residues of carbon dioxide.
  • the said extracts are obtained by enzyme extraction method comprising the steps of: a. Shade drying the material; b. Pulverizing the dried material to coarse powder; c. Placing the material in Stainless Steel container and adding 0.5% to 5% of cellulase and pectinase enzyme combination in 4 volumes of distilled water; d. Processing the enzyme extraction at the temperature of 55°C to 60°C under occasional stirring upto 4-6 hours; and e. Filtering the extract and concentrating the same to dryness on rotatory evaporator or on steam bath at optimum temperature under reduced pressure.
  • the herbal composition is in the form of a tablet, capsule, syrup, injection or any other suitable form.
  • An important aspect of the present invention is to provide a herbal composition which is useful in treating liver disorders such as jaundice, cirrhosis, non-alcoholic fatty liver disease etc. and other liver disorders. More particularly, the invention relates to a herbal composition comprising extracts of Eclipto prostrata whole parts and/or Cichorium intybus seeds and/or Andrographis paniculata whole parts and/or Fumaria indica whole parts and/or Oroxylum indicum leaves and/or Ailanthus excelsa leaves and a pharmaceutically acceptable carrier, methods of obtaining the same, pharmaceutical formulations thereof and methods of using the composition as hepatoprotective.
  • the present invention involves the selection and identification of the herbs and obtaining the extract by subjecting the same to different extraction techniques including conventional solvent extraction and super critical fluid extraction.
  • the following methodologies, examples, and studies of the composition follow the teachings of and illustrate the present invention :
  • the shade dried material of whole plant parts of Eclipta prostrata was pulverized to coarse powder and about 10 Kg each of powdered material placed in different percolators and extracted with n-hexane, acetone, ethyl alcohol, methanol, ethyl alcohol and water (1:1), methanol and water (1 :1) and water at room temperature for 24 h to 48 h., then plant extracts were filtered and concentrated to dryness on rotatory evaporator or on steam bath at optimum temperature and under reduced pressure.
  • the coarse powdered material of whole parts of Eclipta prostrata was subjected to hot- soxlation by placing 10 Kg of material in each soxlator using solvents n-hexane, acetone, ethyl alcohol, methanol, ethyl alcohol and water (1: 1), methanol and water (1:1) and water at refluxing temperature of each solvent and recycled the process until extraction is completed, then plant extracts were filtered and concentrated to dryness on rotatory evaporator or on steam bath at optimum temperatu re.
  • the shade dried material of whole plant parts of Eclipta prostrata was pulverized to powder and about 10 Kg each of powdered material placed in Stainless Steel container and 0.5% to 5% of cellulase and pectinase enzyme combination was added in 4 volumes of distilled water.
  • the enzyme extraction was processed at the temperature of 55°C to 60°C under occasional stirring upto 4-6 hours, and then plant extracts were filtered and concentrated to dryness on rotatory evaporator or on steam bath at optimum temperature and under reduced pressure.
  • the shade dried material of whole plant parts of Eclipta prostrata was pulverized to coarse powder and about 100 Kg of powdered material placed in a SCF extractor at the temperature of 40-50C at high pressure of 300-350 bar using carbon dioxide as super critical fluid for extraction upto 4 to 6 hours and then the extract was collected in the collection vessel and evaporated at room temperature to remove any further residues of carbon dioxide.
  • the extract thus obtained was free from any solvent residues and in highest pure form.
  • the shade dried material of seeds of Cichorium intybus was pulverized to coarse powder and about 10 Kg each of powdered material placed in different percolators and extracted with n-hexane, acetone, ethyl alcohol, methanol, ethyl alcohol and water ( 1: 1), methanol and water ( 1:1) and water at room temperature for 24 h to 48 h., then plant extracts were filtered and concentrated to dryness on rotatory evaporator or on steam bath at optimum temperature and under reduced pressure.
  • the coarse powdered material of seeds of Cichorium intybus was subjected to hot- soxlation by placing 10 Kg of material in each soxlator using solvents n-hexane, acetone, ethyl alcohol, methanol, ethyl alcohol and water (1 :1), methanol and water (1:1) and water at refluxing temperature of each solvent and recycled the process until extraction is completed, then plant extracts were filtered and concentrated to dryness on rotatory evaporator or on steam bath at optimum temperature.
  • the shade dried material of seeds of Cichorium intybus was pulverized to powder and about 10 Kg each of powdered material placed in Stainless Steel container and 0.5% to 5% of cellulase and pectinase enzyme combination was added in 4 volumes of distilled water.
  • the enzyme extraction was processed at the temperature of 55°C to 60°C under occasional stirring upto 4-6 hours, and then plant extracts were filtered and concentrated to dryness on rotatory evaporator or on steam bath at optimum temperature and under reduced pressure.
  • the shade dried material of seeds of Cichorium intybus was pulverized to coarse powder and about 100 Kg of powdered material placed in a SCF extractor at the temperature of 40-50C at high pressure of 300-350 bar using carbon dioxide as super critical fluid for extraction upto 4 to 6 hours and then the extract was collected in the collection vessel and evaporated at room temperature to remove any further residues of carbon dioxide.
  • the extract thus obtained was free from any solvent residues and in highest pure form.
  • the shade dried material of whole plant parts of Andrographis paniculata was pulverized to coarse powder and about 10 Kg each of powdered material placed in different, percolators and extracted with n-hexane, acetone, ethyl alcohol, methanol, ethyl alcohol and water ( 1: 1), methanol and water ( 1 : 1) and water at room temperature for 24 h to 48 h., then plant extracts were filtered and concentrated to dryness on rotatory evaporator or on steam bath at optimum temperature and under reduced pressure .
  • the coarse powdered material of whole parts of Andrographis paniculata was subjected to hot-soxlation by placing 10 Kg of material in each soxlator using solvents n-hexane, acetone, ethyl alcohol, methanol, ethyl alcohol and water ( 1: 1), methanol and water ( 1:1) and water at refluxing temperature of each solvent and recycled the process until extraction is completed, then plant extracts were filtered and concentrated to dryness on rotatory evaporator or on steam bath at optimum temperature.
  • All extracts such as n-hexane extract (AP-1), acetone extract (AP-2), ethyl alcohol extract (AP-3), methanol extract (AP-4), ethyl alcohol and water (1:1) extract (AP-5), methanol and water ( 1: 1) extract (AP-6) and water extract (AP-7) prepared from the whole parts of Andrographis panicuiata by percolation method or hot-soxlation method were subjected to HPTLC (High Performance Thin Layer Chromatography) and H PLC (High performance Liquid chromatography) in various mobile phases on precoated TLC plates (Merck) and ODS column for qualitative and quantitative estimation of marker compounds and active principles.
  • HPTLC High Performance Thin Layer Chromatography
  • H PLC High performance Liquid chromatography
  • the shade dried material of whole plant parts of Andrographis panicuiata was pulverized to powder and about 10 Kg each of powdered material placed in Stainless Steel container and 0.5% to 5% of cellulase and pectinase enzyme combination was added in 4 volumes of distilled water.
  • the enzyme extraction was processed at the temperature of 55°C to 60°C under occasional stirring upto 4-6 hours, and then plant extracts were filtered and concentrated to dryness on rotatory evaporator or on steam bath at optimum temperature and under reduced pressure.
  • the shade dried material of whole plant parts of Fumaria indica was pulverized to coarse powder and about 10 Kg each of powdered material placed in different percolators and extracted with n-hexane, acetone, ethyl alcohol, methanol, ethyl alcohol and water (1:1), methanol and water (1:1) and water at room temperature for 24 h to 48 h., then plant extracts were filtered and concentrated to dryness on rotatory evaporator or on steam bath at optimum temperature and under reduced pressure.
  • the coarse powdered material of whole parts of Fumaria indica was subjected to hot- soxlation by placing 10 Kg of material in each soxlator using solvents n-hexane, acetone, ethyl alcohol, methanol, ethyl alcohol and water (1:1), methanol and water ( 1:1) and water at refluxing temperature of each solvent and recycled the process until extraction is completed, then plant extracts were filtered and concentrated to dryness on rotatory evaporator or on steam bath at optimum temperature.
  • the shade dried material of whole plant parts of Fumario indica was pulverized to powder and about 10 Kg each of powdered material placed in Stainless Steel container and 0.5% to 5% of cellulase and pectinase enzyme combination was added in 4 volumes of distilled water.
  • the enzyme extraction was processed at the temperature of 55°C to 60°C under occasional stirring upto 4-6 hours, and then plant extracts were filtered and concentrated to dryness on rotatory evaporator or on steam bath at optimum temperature and under reduced pressure.
  • the shade dried material of whole plant parts of Fumaria indica was pulverized to coarse powder and about 100 Kg of powdered material placed in a SCF extractor at the temperature of 40-50°C at high pressure of 300-350 bar using carbon dioxide as super critical fluid for extraction upto 4 to 6 hours and then the extract was collected in the collection vessel and evaporated at room temperature to remove any further residues of carbon dioxide.
  • the extract thus obtained was free from any solvent residues and in highest pure form.
  • the coarse powdered material of leaves of Oroxylum indicum was subjected to hot- soxlation by placing 10 Kg of material in each soxlator using solvents n-hexane, acetone, ethyl alcohol, methanol, ethyl alcohol and water (1:1), methanol and water (1 :1) and water at refluxing temperatu re of each solvent and recycled the process until extraction is completed, then plant extracts were filtered and concentrated to dryness on rotatory evaporator or on steam bath at optimum temperatu re.
  • EP All extracts such as n-hexane extract (Ol-l), acetone extract (OI-2), ethyl alcohol extract (01-3), methanol extract (01-4), ethyl alcohol and water ( 1: 1) extract (01-5), methanol and water (1:1) extract (01-6) and water extract (01-7) prepared from the leaves of Oroxylum indicum by percolation method or hot-soxlation method were subjected to H PTLC (High Performance Thin Layer Chromatography) and HPLC (High performance Liquid chromatography) in various mobile phases on precoated TLC plates (Merck) and ODS column for qualitative and quantitative estimation of marker compounds and active principles.
  • H PTLC High Performance Thin Layer Chromatography
  • HPLC High performance Liquid chromatography
  • the shade dried material of herbal blend of whole parts of Eclipta prostrata, seeds of Cichorium intybus, whole parts of Andrographis paniculata, whole parts of Fumaria indica and leaves of Oxoxylum indicum in the ratio of 20:18:30: 15: 17 respectively was pulverized to coarse powder and about 100 Kg of powdered herbal blend was placed in a SCF extractor at the temperature of 40-50°C at high pressure of 300-350 bar using carbon dioxide as super critical fluid for extraction upto 4 to 6 hours and then the extract was collected in the collection vessel and evaporated at room temperature to remove any further residues of carbon dioxide. The extract thus obtained was free from any solvent residues and in highest pure form.
  • the shade dried material of leaves of Ailanthus excelsa was pulverized to coarse powder and about 10 Kg each of powdered material placed in different percolators and extracted with n-hexane, acetone, ethyl alcohol, methanol, ethyl alcohol and water ( 1: 1), methanol and water (1: 1) and water at room temperature for 24 h to 48 h., then plant extracts were filtered and concentrated to dryness on rotatory evaporator or on steam bath at optimum temperature and under reduced pressure.
  • the coarse powdered material of leaves of Ailanthus excelsa was subjected to hot- soxlation by placing 10 Kg of material in each soxlator using solvents n-hexane, acetone, ethyl alcohol, methanol, ethyl alcohol and water (1 :1), methanol and water ( 1:1) and water at refluxing temperature of each solvent and recycled the process until extraction is completed, then plant extracts were filtered and concentrated to dryness on rotatory evaporator or on steam bath at optimum temperature.
  • HPTLC High Performance Thin Layer Chromatography
  • HPLC High performance Liquid chromatography
  • the shade dried material of leaves of Ailanthus excelsa was pulverized to powder and about 10 Kg each of powdered material placed in Stainless Steel container and 0.5% to 5% of cellulase and pectinase enzyme combination was added in 4 volumes of distilled water.
  • the enzyme extraction was processed at the temperature of 55°C to 60°C under occasional stirring upto 4-6 hours, and then plant extracts were filtered and concentrated to dryness on rotatory evaporator or on steam bath at optimum temperature and under reduced pressure.
  • the shade dried material of leaves of Ailanthus excelsa was pulverized to coarse powder and about 100 Kg of powdered material placed in a SCF extractor at the temperature of 40-50°C at high pressure of 300-350 bar using carbon dioxide as super critical fluid for extraction upto 4 to 6 hours and then the extract was collected in the collection vessel and evaporated at room temperature to remove any further residues of carbon dioxide.
  • the extract thus obtained was free from any solvent residues and in highest pure form.
  • the shade dried material of herbal blend of whole parts of Eclipta prostrata, seeds of Cichorium intybus, whole parts of Andrographis paniculata, whole parts of Fumaria indica and leaves of Ailanthus excelsa in the ratio of 20:18:30:15:17 respectively mixed and pulverized to coarse powder and about 10 Kg each of herbal blend placed in different percolators and extracted with n-hexane, acetone, ethyl alcohol, methanol, ethyl alcohol and water (1:1), methanol and water (1:1) and water at room temperature for 24 h to 48 h., then plant extracts were filtered and concentrated to dryness on rotatory evaporator or on steam bath at optimum temperature and under reduced pressure .
  • the coarse powdered material of herbal blend of whole parts of Eclipta prostrata, seeds of Cichorium intybus, whole parts of Andrographis paniculata, whole parts of Fumaria indica and leaves of Ailanthus excelsa in the ratio of 20:18:30:15:17 respectively was subjected to hot-soxlation by placing 10 Kg of herbal blend in each soxlator using solvents n-hexane, acetone, ethyl alcohol, methanol, ethyl alcohol and water (1 :1), methanol and water ( 1:1) and water at refluxing temperature of each solvent and recycled the process until extraction is completed, then plant extracts were filtered and concentrated to dryness on rotatory evaporator or on steam bath at optimum temperature.
  • n-hexane extract NP42-8, also decoded as ERN P-167
  • acetone extract
  • N P42-9 also decoded as ERNP-169
  • ethyl alcohol extract N P42-10, also decoded as ERN P-168
  • methanol extract NP42-11
  • ethyl alcohol and water 1: 1) extract (NP42-12, also decoded as NP42/A/123), methanol and water ( 1:1) extract (NP42-13) and water extract (NP42-14, also decoded as ERN P-172) prepared from the herbal blend by percolation method or hot-soxlation method were subjected to HPTLC (High Performance Thin Layer Chromatography) and HPLC (High performance Liquid chromatography) in various mobile phases on precoated TLC plates (Merck) and ODS column for qualitative and quantitative estimation of marker compounds and active principles.
  • HPTLC High Performance Thin Layer Chromatography
  • HPLC High performance Liquid chromatography
  • the water extract of herbal blend (ERNP-172) was prepared in the pilot scale batch from 100 Kg of herbal blend and the final extract was subjected to spray drying to obtain dry powder extract.
  • This extract was coded as NP-042/A and subjected to animal studies
  • the shade dried material of herbal blend of whole parts of Eclipta prostrata, seeds of Cichorium intybus, whole parts of Andrographis paniculata, whole parts of Fumaria indica and leaves of Ailanthus excelsa in the ratio of 20:18:30:15: 17 respectively was pulverized to powder and about 10 Kg each of powdered herbal blend was placed in Stainless Steel container and 0.5% to 5% of cellulase and pectinase enzyme combination was added in 4 volumes of distilled water.
  • the shade dried material of herbal blend of whole parts of Eclipta prostrata, seeds of Cichorium intybus, whole parts of Andrographis paniculata, whole parts of Fumaria indica and leaves of Ailanthus excelsa in the ratio of 20:18:30: 15:17 respectively was pulverized to coarse powder and about 100 Kg of powdered herbal blend was placed in a SCF extractor at the temperature of 40-50C at high pressure of 300-350 bar using carbon dioxide as super critical fluid for extraction upto 4 to 6 hours and then the extract was collected in the collection vessel and evaporated at room temperature to remove any further residues of carbon dioxide. The extract thus obtained was free from any solvent residues and in highest pure form.
  • OBJECTIVE The objective of the present study was to compare the hepatoprotective potential of N P-042/ERNP variants against carbontetrachloride and thioacetamide- induced hepatic damage in rats.
  • Rats from groups I and II received DM water once a day orally at a dose of 10 ml/kg b.wt. and were served as normal and positive untreated controls respectively.
  • Rats from groups III to VIII received N P-042/ERN P-167, NP-042/ERN P-168, N P-042/ERNP-169, NP-042/ERNP-170, NP-042/ERN P-171 and NP-042/ERNP-172 at a dose of 500 mg/kg, b.wt. respectively. All the rats received the respective assigned treatment for 14 days.
  • Rats from groups I and II received water once a day orally at a dose of 10 ml/kg b.wt. and served as normal and positive untreated controls respectively.
  • Rats from groups III to V received NP-042, N P-042/A, NP-042/A/123, at a dose equivalent to lOOOmg/kg b.wt of extracts respectively.
  • Ail the rats received the respective assigned treatment for 14 days. On day 14, one hour after the respective assigned treatment all the rats, except group I, were administered with hepatotoxin, thioacetamide 50 mg/kg b.wt. by subcutaneous route.
  • blood was collected from the retro-orbital plexus under mild ether anesthesia and subjected for the estimation of SGPT, SGOT and ALP.
  • Rats from groups III to VI received NP-042/A (500mg/kg body wt. per day), N P-042/A ( lOOOmg/kg body wt. per day), NP-042/A/123 (500mg/kg body wt. per day) and N P-042/A/123 ( lOOOmg/kg body wt. per day) respectively. All the rats received the respective assigned treatment for 14 days.
  • the first study (Study-1) was carried out to evaluate and compare the hepatoprotective potential of different N P-042/ERN P variants (NP-042/ERNP-167, N P-042/ERNP-168, N P- 042/ERNP-169, NP-042/ERNP-170, NP-042/ERN P-171 and N P-042/ERN P-172) in a well established experimental model of carbon tetrachloride-induced hepatic damage in rats.
  • the extracts were tested at equal dose but at multiple doses (14 days). For the purpose of testing and comparing, the dose of extracts was fixed at a dose of 500mg/kg/day p.
  • N P-042 extracts (NP-042, NP-042A and N P-042A/123) were evaluated/ compared for their hepatoprotective potential in experimental model of thioacetamide-induced hepatotoxicity in rats.
  • the N P-042 extracts were tested at single dose level of dose level of 1000 mg/kg body weight/ day for 15 days.
  • the thioacetamide-intoxicated rats showed severe and significant derangement in liver function markers like enzymes SGPT, SGOT and serum alkaline phosphatase (ALP).
  • NP-042/A/123 and N P-042/A significantly reversed the elevation of specific serum markers of hepatic damage like, SGPT, SGOT levels in rats with hepatic damage.
  • the reductions in liver markers were also found to be reduced in other extract treated group (NP-042).
  • NP-042A/123 significantly reversed the elevation of serum markers of hepatic damage like, SGPT, SGOT levels in carbon tetrachloride-intoxicated rats at both the tested doses. There is also a decrease in the mean values of the liver marker levels in NP-042A treated groups.
  • LC-MS/MS optimization conditions The LC-MS/MS analysis performed with Shimadzu LC-20 AD Prominence series HPLC system. LC separation was performed on a Reverse phase C18 (250 X4.6mm, 5um) Phenomenex column. The mobile phase consisted of 0.1% acetic acid in water and acetonitrile in a ratio of 90:10 (v/v), delivered at a flow rate of lml/min. The autosamp!er SIL-HTC (Shimadzu maker) injection volume was set at 20 ⁇ . UV detector chromatograms were monitor at 275nm and 254nm.
  • ESI source conditions as follows: declustering potential (DP) 10 V, source gas (GS1) 50 psi and (GS2) 60 psi, curtain gas (CUR) 20psi, ion spray voltage (IS) 5500 V, focusing potential (FP) 400 psi and source temperature (TEM) 428 C were optimized with respect to ionization intensity response of the peak.
  • the major chemical constituents detected in various herbal blend extracts were identified as fumaramine, cichoriin, chlorogenic acid, lactupicrin, protopine, wedeloactone, luteolin, andrographolide etc.
  • Granulation By using Purified Water as a granulating fluid
  • PROCEDURE Active and excipients were sieved through a 36 mesh sieve into a suitable mixer and granulated with a suitable quantity of boiled cooled purified water to form a medium /heavy granule. The granules were dried in a suitable oven at 60°C, until the LOD was ⁇ 2%. The granulation was also tried with Isopropyl alcohol, alcohol etc.
  • Capsule Formulation By using purified water as a granulating fluid.
  • PROCEDURE Active and excipients were sieved through a 36 mesh sieve into a suitable mixer and granulated with a suitable quantity of boiled cooled purified water to form a medium /heavy granule. The granules were dried in a suitable oven at 60°C, until the LOD was ⁇ 2%.

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a herbal composition, more particularly, a composition comprising extracts of Eclipta prostrata whole parts and/or Cichorium intybus seeds and/or Andrographis paniculata whole parts and/or Fumaria indico whole parts and/or Oroxylum indicum leaves and/or Ailanthus excelsa leaves for hepatoprotective and methods of treating liver disorders such as jaundice, cirrhosis, non-alcoholic fatty liver disease etc. and other liver disorders due to infection and chemotherapy in humans using said natural herbal composition.

Description

A HERBAL COMPOSITION AS HEPATOPROTECTIVE AND TREATMENT
FOR LIVER DISORDERS
FIELD OF THE INVENTION
This invention relates to a herbal composition having hepatoprotective activity. More particularly, the invention relates to a composition comprising extracts of Eclipta prostrata whole parts and/or Cichorium intybus seeds and/or Andrographis paniculata whole parts and/or Fumaria indica whole parts and/or Oroxylum indicum leaves and/or Ailanthus excelsa leaves and a pharmaceutically acceptable carrier, methods of obtaining the same, pharmaceutical formulations thereof and methods of using the composition as hepatoprotective which is useful in treating liver disorders such as jaundice, cirrhosis, non-alcoholic fatty liver disease etc. and other liver disorders due to infection and chemotherapy in humans using said natural herbal composition.
BACKGROUND OF THE INVENTION
Day by day we are identifying new and more powerful agents to prevent, treat, or retard infections and cure the diseases they cause. Billions of dollars are being spent every year in just identifying, locating, and developing these new drugs. However, till now effective therapies for many of the common disease like liver, heart, kidney etc. are still elusive.
At present, most patients are treated with drugs that are very effective over a short term. However, they have very adverse effect on long term use. They are also very expensive and demonstrate many side effects and uncertain activities.
In comparison to the above, the herbal compositions are very effective in curing such diseases in a very efficient manner without any side effects. The herbal composition prepared for liver helps in restoring the metabolic efficiency of the liver by protecting the hepatic parenchyma and promoting hepatocellular regeneration. It also helps in preventing the loss of functional integrity of the cell membrane and in restoring the hepatic function in infective hepatitis.
SUMMARY OF THE INVENTION This invention relates to herbal composition which is useful in treating liver disorders such as jaundice, cirrhosis, non-alcoholic fatty liver disease etc. and other liver disorders. More particularly, the invention relates to a herbal composition comprising extracts of Eclipta prostrate whole parts and/or Cichorium intybus seeds and/or Andrographis paniculata whole parts and/or Fumaria indica whole parts and/or Oroxylum indicum leaves and/or Ailanthus excelsa leaves and a pharmaceutically acceptable carrier, methods of obtaining the same, pharmaceutical formulations thereof and methods of using the composition as hepatoprotective agent.
Further, the present invention relates to the selection and identification of the herbs and obtaining the extract by subjecting the same to different extraction techniques including conventional solvent extraction and super critical fluid extraction. The bioassay guided fractionation of the extract or combination thereof to identify the active markers or active fraction and to develop effective and safe composition for the use in human beings and animals as hepatoprotective agent and treatment for all kinds of liver disorders such as jaundice, cirrhosis, non-alcoholic fatty liver disease and other liver disorders due to infection and chemotherapy in humans.
BRIEF DESCRIPTION OF DRAWINGS
FIG.l depicts the effect of N P-042/ERNP variants on SGPT level of rats in an experimental model of carbon tetrachloride-induced hepatic damage in rats.
FIG.2 depicts the effect of N P-042/ERN P variants on SGOT level of
experimental model of carbon tetrachloride-induced hepatic damage in rats. FIG.3 depicts the effect of N P-042/ERNP variants on liver glycogen content of rats in an experimental model of carbon tetrachloride-induced hepatic damage in rats. FIG. depicts the comparative evaluation of NP-42 variants for Hepatoprotective activity in an experimental model of thioacetamide induced hepatic damage in rats.
FIG.5 depicts the comparative evaluation of NP-42 variants for Hepatoprotective activity in an experimental model of thioacetamide induced hepatic damage in rats.
FIG.6 depicts the comparative evaluation of NP-42 variants for Hepatoprotective activity in an experimental model of thioacetamide induced hepatic damage in rats.
FIG.7 depicts the comparative evaluation of NP-42 variants in an experimental model of carbon tetrachloride -induced hepatic damage in rats.
FIG.8 depicts the comparative evaluation of N P-42 variants in an experimental model of carbon tetrachloride induced hepatic damage in rats. FIG.9 depicts the comparative evaluation of NP-42 variants in an experimental model of carbon tetrachloride induced hepatic damage in rats.
EMBODIMENT OF THE INVENTION In an embodiment of proposed invention a herbal composition having hepatoprotective activity comprises effective amounts of extracts of Eclipta prostrato, Cichorium intybus, Andrographis paniculata, Fumaria indica, Ailanthus excelsa and suitable pharmaceutically acceptable carriers and additives. In another embodiment of the invention the herbal extracts are obtained either by separate extraction or from the blend of Eclipta prostrata, Cichorium intybus, Andrographis paniculata, Fumaria indica, Ailanthus excelsa parts. In another embodiment of the invention the herbal extracts are obtained from the specific parts of the herbs preferably whole parts of Eclipta prostrata, seeds of Cichorium intybus, whole parts of Andrographis paniculata, whole parts of Fumaria indica and leaves of Ailanthus excelsa. In still another embodiment of the invention the blend of herbs comprises whole parts of Eclipta prostrata, seeds of Cichorium intybus, whole parts of Andrographis paniculata, whole parts of Fumaria indica and leaves of Ailanthus excelsa in the ratio of 20:18:30: 15 :17 respectively. In still another embodiment of the invention a herbal composition having hepato- protective activity comprises effective amounts of extracts of Eclipta prostrata, Cichorium intybus, Andrographis paniculata, Fumaria indica, Oxoxylum indicum and suitable pharmaceutically acceptable carrier and additives. In still another embodiment of the invention the herbal extracts are obtained either by separate extraction or from the blend of Eclipta prostrata, Cichorium intybus, Andrographis paniculata, Fumaria indica, Oxoxylum indicum parts.
In yet another embodiment of the invention the herbal extracts are obtained from the specific pa rts of the herbs preferably whole parts of Eclipta prostrata, seeds of Cichorium intybus, whole parts of Andrographis paniculata, whole parts of Fumaria indica and leaves of Oxoxylum indicum. In still another embodiment of the invention the blend of herbs comprises whole parts of Eclipta prostrota, seeds of Cichorium intybus, whole parts of Andrographis paniculata, whole parts of Fumaria indica and leaves of Oxoxylum indicum in the ratio of 20:18:30:15:17 respectively. In still another embodiment of the invention the extracts are obtained by method selected from the group of percolation method, hot - soxlation method, super - critical - fluid method or enzyme extraction method.
In still another embodiment the said extracts are obtained by percolation method comprising the following steps of: . a. Shade drying the material; b. Pulverizing the material obtained in step a. to coarse powder; c. Placing the powdered material in different percolators and extracting with n-hexane, acetone, ethyl alcohol, methanol, ethyl alcohol and water (1:1), methanol and water (1:1) and water at room temperature for 24 h to 48 h.; and d. Filtering the plant extracts and concentrating to dryness using a rotatory evaporator or on steam bath at optimum temperature under reduced pressure.
In still another embodiment the said extracts are obtained by hot-soxlation method comprising the steps of:
a. Placing the coarse powdered material in each soxlator using solvents n- hexane, acetone, ethyl alcohol, methanol, ethyl alcohol and water (1:1), methanol and water ( 1 :1) and water at refluxing temperature of each solvent;
b. recycling the process until extraction is completed; and
c. filtering the plant extracts and concentrating to dryness using rotatory evaporator or on steam bath at optimum temperature.
In still another embodiment the said extracts are obtained by super - critical - fluid extraction method comprising the steps of: a. Shade drying the material; b. Pulverizing the dried material to coarse powder; c. Placing the material in a SCF extractor at the temperature ranging from 40-50 °C at high pressure range of 300-350 bar using carbon dioxide as super critical fluid for extraction upto 4 to 6 hours; and d. Collecting the extract in the collection vessel and evaporating at room temperature to remove any further residues of carbon dioxide.
In another embodiment the said extracts are obtained by enzyme extraction method comprising the steps of: a. Shade drying the material; b. Pulverizing the dried material to coarse powder; c. Placing the material in Stainless Steel container and adding 0.5% to 5% of cellulase and pectinase enzyme combination in 4 volumes of distilled water; d. Processing the enzyme extraction at the temperature of 55°C to 60°C under occasional stirring upto 4-6 hours; and e. Filtering the extract and concentrating the same to dryness on rotatory evaporator or on steam bath at optimum temperature under reduced pressure.
In another embodiment the herbal composition is in the form of a tablet, capsule, syrup, injection or any other suitable form.
DETAILED DESCRIPTION OF THE INVENTION
An important aspect of the present invention is to provide a herbal composition which is useful in treating liver disorders such as jaundice, cirrhosis, non-alcoholic fatty liver disease etc. and other liver disorders. More particularly, the invention relates to a herbal composition comprising extracts of Eclipto prostrata whole parts and/or Cichorium intybus seeds and/or Andrographis paniculata whole parts and/or Fumaria indica whole parts and/or Oroxylum indicum leaves and/or Ailanthus excelsa leaves and a pharmaceutically acceptable carrier, methods of obtaining the same, pharmaceutical formulations thereof and methods of using the composition as hepatoprotective.
Further, the present invention involves the selection and identification of the herbs and obtaining the extract by subjecting the same to different extraction techniques including conventional solvent extraction and super critical fluid extraction. The bioassay guided fractionation of the extract or combination thereof to identify the active markers or active fraction and to develop effective and safe composition for the use in human beings and animals as hepatoprotective agent and treatment for all kinds of liver disorders such as jaundice, cirrhosis, non-alcoholic fatty liver disease and other liver disorders due to infection and chemotherapy in humans. The following methodologies, examples, and studies of the composition follow the teachings of and illustrate the present invention :
Example 1
Preparation of extract from Eclipta prostrata by percolation method
The shade dried material of whole plant parts of Eclipta prostrata was pulverized to coarse powder and about 10 Kg each of powdered material placed in different percolators and extracted with n-hexane, acetone, ethyl alcohol, methanol, ethyl alcohol and water (1:1), methanol and water (1 :1) and water at room temperature for 24 h to 48 h., then plant extracts were filtered and concentrated to dryness on rotatory evaporator or on steam bath at optimum temperature and under reduced pressure.
Example 2
Preparation of extract from Eclipta prostrate by hot-soxlation method
The coarse powdered material of whole parts of Eclipta prostrata was subjected to hot- soxlation by placing 10 Kg of material in each soxlator using solvents n-hexane, acetone, ethyl alcohol, methanol, ethyl alcohol and water (1: 1), methanol and water (1:1) and water at refluxing temperature of each solvent and recycled the process until extraction is completed, then plant extracts were filtered and concentrated to dryness on rotatory evaporator or on steam bath at optimum temperatu re.
All extracts such as n-hexane extract (EP-1), acetone extract (EP-2 ), ethyl alcohol extract (EP-3), methanol extract (EP-4), ethyl alcohol and water ( 1:1) extract (EP-5), methanol and water (1:1) extract (EP-6) and water extract (EP-7) prepared from the whole parts of Eclipta prostrata by percolation method or hot-soxlation method were subjected to HPTLC (High Performance Thin Layer Chromatography) and HPLC (High performance Liquid chromatography) in various mobile phases on precoated TLC plates (Merck) and ODS column for qualitative and quantitative estimation of marker compounds and active principles. Example 3
Preparation of extract from Eclipta prostrata by Enzyme extraction
The shade dried material of whole plant parts of Eclipta prostrata was pulverized to powder and about 10 Kg each of powdered material placed in Stainless Steel container and 0.5% to 5% of cellulase and pectinase enzyme combination was added in 4 volumes of distilled water. The enzyme extraction was processed at the temperature of 55°C to 60°C under occasional stirring upto 4-6 hours, and then plant extracts were filtered and concentrated to dryness on rotatory evaporator or on steam bath at optimum temperature and under reduced pressure.
Example 4
Preparation of extract from Eclipta prostrata by Super Critical Fluid Extraction
The shade dried material of whole plant parts of Eclipta prostrata was pulverized to coarse powder and about 100 Kg of powdered material placed in a SCF extractor at the temperature of 40-50C at high pressure of 300-350 bar using carbon dioxide as super critical fluid for extraction upto 4 to 6 hours and then the extract was collected in the collection vessel and evaporated at room temperature to remove any further residues of carbon dioxide. The extract thus obtained was free from any solvent residues and in highest pure form.
Example 5
Preparation of extract from Cichorium intybus by percolation method
The shade dried material of seeds of Cichorium intybus was pulverized to coarse powder and about 10 Kg each of powdered material placed in different percolators and extracted with n-hexane, acetone, ethyl alcohol, methanol, ethyl alcohol and water ( 1: 1), methanol and water ( 1:1) and water at room temperature for 24 h to 48 h., then plant extracts were filtered and concentrated to dryness on rotatory evaporator or on steam bath at optimum temperature and under reduced pressure.
Example 6
Preparation of extract from Cichorium intybus by hot-soxlation method
The coarse powdered material of seeds of Cichorium intybus was subjected to hot- soxlation by placing 10 Kg of material in each soxlator using solvents n-hexane, acetone, ethyl alcohol, methanol, ethyl alcohol and water (1 :1), methanol and water (1:1) and water at refluxing temperature of each solvent and recycled the process until extraction is completed, then plant extracts were filtered and concentrated to dryness on rotatory evaporator or on steam bath at optimum temperature.
All extracts such as n-hexane extract (Cl- l), acetone extract (CI-2 ), ethyl alcohol extract (CI-3), methanol extract (CI-4), ethyl alcohol and water ( 1: 1) extract (CI-5), methanol and water ( 1: 1) extract (CI-6) and water extract (CI-7) prepared from the whole parts of Cichorium intybus by percolation method or hot-soxlation method were subjected to HPTLC (High Performance Thin Layer Chromatography) and HPLC (High performance Liquid chromatography) in various mobile phases on precoated TLC plates (Merck) and ODS column for qualitative and quantitative estimation of marker compounds and active principles.
Example 7
Preparation of extract from Cichorium intybus by Enzyme extraction
The shade dried material of seeds of Cichorium intybus was pulverized to powder and about 10 Kg each of powdered material placed in Stainless Steel container and 0.5% to 5% of cellulase and pectinase enzyme combination was added in 4 volumes of distilled water. The enzyme extraction was processed at the temperature of 55°C to 60°C under occasional stirring upto 4-6 hours, and then plant extracts were filtered and concentrated to dryness on rotatory evaporator or on steam bath at optimum temperature and under reduced pressure.
Example 8
Preparation of extract from Cichorium intybus by Super Critical Fluid Extraction
The shade dried material of seeds of Cichorium intybus was pulverized to coarse powder and about 100 Kg of powdered material placed in a SCF extractor at the temperature of 40-50C at high pressure of 300-350 bar using carbon dioxide as super critical fluid for extraction upto 4 to 6 hours and then the extract was collected in the collection vessel and evaporated at room temperature to remove any further residues of carbon dioxide. The extract thus obtained was free from any solvent residues and in highest pure form.
Example 9
Preparation of extract from Andrographis paniculata by percolation method
The shade dried material of whole plant parts of Andrographis paniculata was pulverized to coarse powder and about 10 Kg each of powdered material placed in different, percolators and extracted with n-hexane, acetone, ethyl alcohol, methanol, ethyl alcohol and water ( 1: 1), methanol and water ( 1 : 1) and water at room temperature for 24 h to 48 h., then plant extracts were filtered and concentrated to dryness on rotatory evaporator or on steam bath at optimum temperature and under reduced pressure .
ExamplelO
Preparation of extract from Andrographis paniculata by hot-soxlation method
The coarse powdered material of whole parts of Andrographis paniculata was subjected to hot-soxlation by placing 10 Kg of material in each soxlator using solvents n-hexane, acetone, ethyl alcohol, methanol, ethyl alcohol and water ( 1: 1), methanol and water ( 1:1) and water at refluxing temperature of each solvent and recycled the process until extraction is completed, then plant extracts were filtered and concentrated to dryness on rotatory evaporator or on steam bath at optimum temperature.
All extracts such as n-hexane extract (AP-1), acetone extract (AP-2), ethyl alcohol extract (AP-3), methanol extract (AP-4), ethyl alcohol and water (1:1) extract (AP-5), methanol and water ( 1: 1) extract (AP-6) and water extract (AP-7) prepared from the whole parts of Andrographis panicuiata by percolation method or hot-soxlation method were subjected to HPTLC (High Performance Thin Layer Chromatography) and H PLC (High performance Liquid chromatography) in various mobile phases on precoated TLC plates (Merck) and ODS column for qualitative and quantitative estimation of marker compounds and active principles.
Example 11
Preparation of extract from Andrographis panicuiata by Enzyme extraction
The shade dried material of whole plant parts of Andrographis panicuiata was pulverized to powder and about 10 Kg each of powdered material placed in Stainless Steel container and 0.5% to 5% of cellulase and pectinase enzyme combination was added in 4 volumes of distilled water. The enzyme extraction was processed at the temperature of 55°C to 60°C under occasional stirring upto 4-6 hours, and then plant extracts were filtered and concentrated to dryness on rotatory evaporator or on steam bath at optimum temperature and under reduced pressure.
Examplel2
Preparation of extract from Andrographis panicuiata by Super Critical Fluid Extraction The shade dried material of whole plant parts of Andrographis panicuiata was pulverized to coarse powder and about 100 Kg of powdered material placed in a SCF extractor at the temperature of 40-50°C at high pressu re of 300-350 bar using carbon dioxide as super critical fluid for extraction upto 4 to 6 hours and then the extract was collected in the collection vessel and evaporated at room temperature to remove any further residues of carbon dioxide. The extract thus obtained was free from any solvent residues and in highest pure form. Example 13
Preparation of extract from Fumaria indica by percolation method
The shade dried material of whole plant parts of Fumaria indica was pulverized to coarse powder and about 10 Kg each of powdered material placed in different percolators and extracted with n-hexane, acetone, ethyl alcohol, methanol, ethyl alcohol and water (1:1), methanol and water (1:1) and water at room temperature for 24 h to 48 h., then plant extracts were filtered and concentrated to dryness on rotatory evaporator or on steam bath at optimum temperature and under reduced pressure.
Example 14
Preparation of extract from Fumaria indica by hot-soxlation method
The coarse powdered material of whole parts of Fumaria indica was subjected to hot- soxlation by placing 10 Kg of material in each soxlator using solvents n-hexane, acetone, ethyl alcohol, methanol, ethyl alcohol and water (1:1), methanol and water ( 1:1) and water at refluxing temperature of each solvent and recycled the process until extraction is completed, then plant extracts were filtered and concentrated to dryness on rotatory evaporator or on steam bath at optimum temperature.
All extracts such as n-hexane extract (Fl- l), acetone extract (FI-2), ethyl alcohol extract (FI-3), methanol extract (FI-4), ethyl alcohol and water ( 1: 1) extract (FI-5), methanol and water (1: 1) extract (FI-6) and water extract ( FI-7) prepared from the whole parts of Fumaria indica by percolation method or hot-soxlation method were subjected to HPTLC (High Performance Thin Layer Chromatography) and HPLC (High performance Liquid chromatography) in various mobile phases on precoated TLC plates (Merck) and ODS column for qualitative and quantitative estimation of marker compounds and active principles.
Example 15
Preparation of extract from Fumoria indica by Enzyme extraction
The shade dried material of whole plant parts of Fumario indica was pulverized to powder and about 10 Kg each of powdered material placed in Stainless Steel container and 0.5% to 5% of cellulase and pectinase enzyme combination was added in 4 volumes of distilled water. The enzyme extraction was processed at the temperature of 55°C to 60°C under occasional stirring upto 4-6 hours, and then plant extracts were filtered and concentrated to dryness on rotatory evaporator or on steam bath at optimum temperature and under reduced pressure.
Example 16
Preparation of extract from Fumoria indica by Super Critical Fluid Extraction
The shade dried material of whole plant parts of Fumaria indica was pulverized to coarse powder and about 100 Kg of powdered material placed in a SCF extractor at the temperature of 40-50°C at high pressure of 300-350 bar using carbon dioxide as super critical fluid for extraction upto 4 to 6 hours and then the extract was collected in the collection vessel and evaporated at room temperature to remove any further residues of carbon dioxide. The extract thus obtained was free from any solvent residues and in highest pure form.
Example 17
Preparation of extract from Oroxylum indicum by percolation method
The shade dried material of leaves of Oroxylum indicum was pulverized to coarse powder and about 10 Kg each of powdered material placed in different percolators and extracted with n-hexane, acetone, ethyl alcohol, methanol, ethyl alcohol and water (1: 1), methanol and water ( 1:1) and water at room temperature for 24 h to 48 h., then plant extracts were filtered and concentrated to dryness on rotatory evaporator or on steam bath at optimum temperature and under reduced pressure. Example 18
Preparation of extract from Oroxylum indicum by hot-soxlation method
The coarse powdered material of leaves of Oroxylum indicum was subjected to hot- soxlation by placing 10 Kg of material in each soxlator using solvents n-hexane, acetone, ethyl alcohol, methanol, ethyl alcohol and water (1:1), methanol and water (1 :1) and water at refluxing temperatu re of each solvent and recycled the process until extraction is completed, then plant extracts were filtered and concentrated to dryness on rotatory evaporator or on steam bath at optimum temperatu re.
EP All extracts such as n-hexane extract (Ol-l), acetone extract (OI-2), ethyl alcohol extract (01-3), methanol extract (01-4), ethyl alcohol and water ( 1: 1) extract (01-5), methanol and water (1:1) extract (01-6) and water extract (01-7) prepared from the leaves of Oroxylum indicum by percolation method or hot-soxlation method were subjected to H PTLC (High Performance Thin Layer Chromatography) and HPLC (High performance Liquid chromatography) in various mobile phases on precoated TLC plates (Merck) and ODS column for qualitative and quantitative estimation of marker compounds and active principles.
Example 19
Preparation of extract from Oroxylum indicum by Enzyme extraction
The shade dried material of leaves of Oroxylum indicum was pulverized to powder and about 10 Kg each of powdered material placed in Stainless Steel container and 0.5% to 5% of cellulase and pectinase enzyme combination was added in 4 volumes of distilled water. The enzyme extraction was processed at the temperature of 55°C to 60°C under occasional stirring upto 4-6 hours, and then plant extracts were filtered and concentrated to dryness on rotatory evaporator or on steam bath at optimum temperature and under reduced pressure. Example 20
Preparation of extract from Oroxylum indicum by Super Critical Fluid Extraction
The shade dried material of leaves of Oroxylum indicum was pulverized to coarse powder and about 100 Kg of powdered material placed in a SCF extractor at the temperature of 40-50°C at high pressure of 300-350 bar using carbon dioxide as super critical fluid for extraction upto 4 to 6 hou rs and then the extract was collected in the collection vessel and evaporated at room temperature to remove any further residues of carbon dioxide. The extract thus obtained was free from any solvent residues and in highest pure form. Example 21
Preparation of extract from Herbal Blend by percolation method
The shade dried material of herbal blend of whole parts of Eclipta prostrata, seeds of Cichorium intybus, whole parts of Andrographis poniculata, whole parts of Fumaria indica and leaves of Oxoxylum indicum in the ratio of 20:18:30:15: 17 respectively mixed and pulverized to coarse powder and about 10 Kg each of herbal blend placed in different percolators and extracted with n-hexane, acetone, ethyl alcohol, methanol, ethyl alcohol and water (1: 1), methanol and water ( 1:1) and water at room temperature for 24 h to 48 h., then plant extracts were filtered and concentrated to dryness on rotatory evaporator or on steam bath at optimum temperature and under reduced pressure .
Example 22
Preparation of extract from Herbal Blend by hot-soxlation method The coarse powdered material of herbal blend of whole parts of Eclipto prostrata, seeds of Cichorium intybus, whole parts of Andrographis paniculata, whole parts of Fumaria indica and leaves of Oxoxylum indicum in the ratio of 20: 18:30: 15:17 respectively was subjected to hot-soxlation by placing 10 Kg of herbal blend in each soxlator using solvents n-hexane, acetone, ethyl alcohol, methanol, ethyl alcohol and water ( 1:1), methanol and water ( 1:1) and water at refluxing temperature of each solvent and recycled the process until extraction is completed, then plant extracts were filtered and concentrated to dryness on rotatory evaporator or on steam bath at optimum temperature.
All extracts such as n-hexane extract (NP42-1), acetone extract (NP42-2 ), ethyl alcohol extract (NP42-3), methanol extract (N P42-4), ethyl alcohol and water ( 1 : 1) extract (NP42-5), methanol and water ( 1 : 1) extract (N P42-6) and water extract (N P42 -7) prepared from the herbal blend by percolation method or hot-soxlation method were subjected to H PTLC (High Performance Thin Layer Chromatography) and HPLC ( High performance Liquid chromatography) in various mobile phases on precoated TLC plates (Merck) and ODS column for qualitative and quantitative estimation of marker compounds and active principles. The water extract of herbal blend was prepared in the pilot scale batch from 100 Kg of herbal blend and the final extract was subjected to spray drying to obtain dry powder extract. This extract was coded as NP-042 and subjected to animal studies.
Example 23
Preparation of extract from herbal blend by Enzyme extraction
The shade dried material of herbal blend of whole parts of Eclipta prostrata, seeds of Cichorium intybus, whole parts of Andrographis paniculata, whole parts of Fumaria indica and leaves of Oxoxylum indicum in the ratio of 20: 18:30: 15:17 respectively was pulverized to powder and about 10 Kg each of powdered herbal blend was placed in Stainless Steel container and 0.5% to 5% of cellulase and pectinase enzyme combination was added in 4 volumes of distilled "water. The enzyme extraction was processed at the temperature of 55°C to 60°C under occasional stirring upto 4-6 hours, and then plant extracts were filtered and concentrated to dryness on rotatory evaporator or on steam bath at optimum temperature and under reduced pressure. The yields of single and herbal blend enzyme extracts are mentioned in below table.
Table-1
Figure imgf000020_0001
Example 24
Preparation of extract from herbal blend by Super Critical Fluid Extraction
The shade dried material of herbal blend of whole parts of Eclipta prostrata, seeds of Cichorium intybus, whole parts of Andrographis paniculata, whole parts of Fumaria indica and leaves of Oxoxylum indicum in the ratio of 20:18:30: 15: 17 respectively was pulverized to coarse powder and about 100 Kg of powdered herbal blend was placed in a SCF extractor at the temperature of 40-50°C at high pressure of 300-350 bar using carbon dioxide as super critical fluid for extraction upto 4 to 6 hours and then the extract was collected in the collection vessel and evaporated at room temperature to remove any further residues of carbon dioxide. The extract thus obtained was free from any solvent residues and in highest pure form.
Example 25
Preparation of extract from Ailanthus excelsa by percolation method;
The shade dried material of leaves of Ailanthus excelsa was pulverized to coarse powder and about 10 Kg each of powdered material placed in different percolators and extracted with n-hexane, acetone, ethyl alcohol, methanol, ethyl alcohol and water ( 1: 1), methanol and water (1: 1) and water at room temperature for 24 h to 48 h., then plant extracts were filtered and concentrated to dryness on rotatory evaporator or on steam bath at optimum temperature and under reduced pressure.
Example 26
Preparation of extract from Ailanthus excelsa by hot-soxlation method:
The coarse powdered material of leaves of Ailanthus excelsa was subjected to hot- soxlation by placing 10 Kg of material in each soxlator using solvents n-hexane, acetone, ethyl alcohol, methanol, ethyl alcohol and water (1 :1), methanol and water ( 1:1) and water at refluxing temperature of each solvent and recycled the process until extraction is completed, then plant extracts were filtered and concentrated to dryness on rotatory evaporator or on steam bath at optimum temperature.
All extracts such as n-hexane extract (AE-1), acetone extract (AE-2), ethyl alcohol extract (AE-3), methanol extract (AE-4), ethyl alcohol and water ( 1: 1) extract (AE-5), methanol and water (1:1) extract (AE-6) and water extract (AE-7) prepared from the leaves of Ailanthus excelsa by percolation method or hot-soxlation method were subjected to HPTLC (High Performance Thin Layer Chromatography) and HPLC (High performance Liquid chromatography) in various mobile phases on precoated TLC plates (Merck) and ODS column for qualitative and quantitative estimation of marker compounds and active principles.
Example 27
Preparation of extract from Ailanthus excelsa by Enzyme extraction
The shade dried material of leaves of Ailanthus excelsa was pulverized to powder and about 10 Kg each of powdered material placed in Stainless Steel container and 0.5% to 5% of cellulase and pectinase enzyme combination was added in 4 volumes of distilled water. The enzyme extraction was processed at the temperature of 55°C to 60°C under occasional stirring upto 4-6 hours, and then plant extracts were filtered and concentrated to dryness on rotatory evaporator or on steam bath at optimum temperature and under reduced pressure.
Example 28
Preparation of extract from Ailanthus excelsa by Super Critical Fluid Extraction
The shade dried material of leaves of Ailanthus excelsa was pulverized to coarse powder and about 100 Kg of powdered material placed in a SCF extractor at the temperature of 40-50°C at high pressure of 300-350 bar using carbon dioxide as super critical fluid for extraction upto 4 to 6 hours and then the extract was collected in the collection vessel and evaporated at room temperature to remove any further residues of carbon dioxide. The extract thus obtained was free from any solvent residues and in highest pure form.
Example 29
Preparation of extract from Herbal Blend by percolation method :
The shade dried material of herbal blend of whole parts of Eclipta prostrata, seeds of Cichorium intybus, whole parts of Andrographis paniculata, whole parts of Fumaria indica and leaves of Ailanthus excelsa in the ratio of 20:18:30:15:17 respectively mixed and pulverized to coarse powder and about 10 Kg each of herbal blend placed in different percolators and extracted with n-hexane, acetone, ethyl alcohol, methanol, ethyl alcohol and water (1:1), methanol and water (1:1) and water at room temperature for 24 h to 48 h., then plant extracts were filtered and concentrated to dryness on rotatory evaporator or on steam bath at optimum temperature and under reduced pressure .
Example 30
Preparation of extract from Herbal Blend by hot-soxlation method:
The coarse powdered material of herbal blend of whole parts of Eclipta prostrata, seeds of Cichorium intybus, whole parts of Andrographis paniculata, whole parts of Fumaria indica and leaves of Ailanthus excelsa in the ratio of 20:18:30:15:17 respectively was subjected to hot-soxlation by placing 10 Kg of herbal blend in each soxlator using solvents n-hexane, acetone, ethyl alcohol, methanol, ethyl alcohol and water (1 :1), methanol and water ( 1:1) and water at refluxing temperature of each solvent and recycled the process until extraction is completed, then plant extracts were filtered and concentrated to dryness on rotatory evaporator or on steam bath at optimum temperature. All extracts such as n-hexane extract (NP42-8, also decoded as ERN P-167), acetone , extract (N P42-9, also decoded as ERNP-169 ), ethyl alcohol extract (N P42-10, also decoded as ERN P-168), methanol extract (NP42-11), ethyl alcohol and water ( 1: 1) extract (NP42-12, also decoded as NP42/A/123), methanol and water ( 1:1) extract (NP42-13) and water extract (NP42-14, also decoded as ERN P-172) prepared from the herbal blend by percolation method or hot-soxlation method were subjected to HPTLC (High Performance Thin Layer Chromatography) and HPLC (High performance Liquid chromatography) in various mobile phases on precoated TLC plates (Merck) and ODS column for qualitative and quantitative estimation of marker compounds and active principles.
The water extract of herbal blend (ERNP-172) was prepared in the pilot scale batch from 100 Kg of herbal blend and the final extract was subjected to spray drying to obtain dry powder extract. This extract was coded as NP-042/A and subjected to animal studies
Example 31
Preparation of extract from herbal blend by Enzyme extraction
The shade dried material of herbal blend of whole parts of Eclipta prostrata, seeds of Cichorium intybus, whole parts of Andrographis paniculata, whole parts of Fumaria indica and leaves of Ailanthus excelsa in the ratio of 20:18:30:15: 17 respectively was pulverized to powder and about 10 Kg each of powdered herbal blend was placed in Stainless Steel container and 0.5% to 5% of cellulase and pectinase enzyme combination was added in 4 volumes of distilled water. The enzyme extraction was processed at the temperature of 55°C to 60°C under occasional stirring upto 4-6 hours, and then plant extracts (coded as ERNP-170) were filtered and concentrated to dryness on rotatory evaporator or on steam bath at optimum temperatu re and under reduced pressure. Example 32
Preparation of extract from herbal blend by Super Critical Fluid Extraction
The shade dried material of herbal blend of whole parts of Eclipta prostrata, seeds of Cichorium intybus, whole parts of Andrographis paniculata, whole parts of Fumaria indica and leaves of Ailanthus excelsa in the ratio of 20:18:30: 15:17 respectively was pulverized to coarse powder and about 100 Kg of powdered herbal blend was placed in a SCF extractor at the temperature of 40-50C at high pressure of 300-350 bar using carbon dioxide as super critical fluid for extraction upto 4 to 6 hours and then the extract was collected in the collection vessel and evaporated at room temperature to remove any further residues of carbon dioxide. The extract thus obtained was free from any solvent residues and in highest pure form.
Example 33
Animal studies: Comparative evaluation of NP-042 variants in an experimental model of carbon tetrachloride and thioacetamide induced hepatic damage in rats
OBJECTIVE : The objective of the present study was to compare the hepatoprotective potential of N P-042/ERNP variants against carbontetrachloride and thioacetamide- induced hepatic damage in rats.
Studv-1
Evaluation of different NP-042/ERNP extracts in an experimental model of carbon tetrachloride-induced hepatic damage in rats:
Eighty male Wistar rats were divided in to eight groups ten each. The rats from groups I and II received DM water once a day orally at a dose of 10 ml/kg b.wt. and were served as normal and positive untreated controls respectively. Rats from groups III to VIII received N P-042/ERN P-167, NP-042/ERN P-168, N P-042/ERNP-169, NP-042/ERNP-170, NP-042/ERN P-171 and NP-042/ERNP-172 at a dose of 500 mg/kg, b.wt. respectively. All the rats received the respective assigned treatment for 14 days. On day 14, one hour after the respective assigned treatment all the rats, except group I, were administered with carbon tetrachloride at a dose of 0.5ml/kg, b.wt. in the form of equal mixture with liquid paraffin. In other words, it was given at the dose of lml/kg, b.wt. of carbon tetrachloride and liquid paraffin mixture (1:1 ratio). On 15th day, 16 to 18 hrs post carbon tetrachloride administration, the blood was collected from the retro-orbital plexus under mild ether anesthesia and subjected for the estimation of markers of liver function such as SGPT and SGOT. The rats were sacrificed using deep ether anesthesia, Liver was weighed and small portion of liver was homogenized and subjected for estimation of glycogen.
Studv-2
Evaluation of different NP-042 extracts in an experimental model of thioacetamide- induced hepatic damage in rats:
Forty inbred male Wistar rats were divided in to 5 groups of 8 each. The rats from groups I and II received water once a day orally at a dose of 10 ml/kg b.wt. and served as normal and positive untreated controls respectively. Rats from groups III to V received NP-042, N P-042/A, NP-042/A/123, at a dose equivalent to lOOOmg/kg b.wt of extracts respectively. Ail the rats received the respective assigned treatment for 14 days. On day 14, one hour after the respective assigned treatment all the rats, except group I, were administered with hepatotoxin, thioacetamide 50 mg/kg b.wt. by subcutaneous route. On 15th day, blood was collected from the retro-orbital plexus under mild ether anesthesia and subjected for the estimation of SGPT, SGOT and ALP.
Studv-3
Evaluation of N P-042 A and NP-042 A/123 extracts in an experimental model of carbon tetrachloride-induced hepatic damage in rats:
Forty-eight male Wistar rats were randomized to 6 groups of eight each. The rats of groups I and II received DM water once a day orally at a dose of 10 ml/kg b.wt. and were served as normal and untreated positive controls respectively. Rats from groups III to VI received NP-042/A (500mg/kg body wt. per day), N P-042/A ( lOOOmg/kg body wt. per day), NP-042/A/123 (500mg/kg body wt. per day) and N P-042/A/123 ( lOOOmg/kg body wt. per day) respectively. All the rats received the respective assigned treatment for 14 days. On day 14, one hour after the respective assigned treatment all the rats, except group I, were administered with carbon tetrachloride at a dose of 0.5ml/kg, b.wt. in the form of equal mixture with liquid paraffin. In other words, it was given at the dose of lml/kg, body weight of carbon tetrachloride and liquid paraffin mixture (1:1 ratio). On 15th day, 16 to 18 hrs post carbon tetrachloride administration, the blood was collected from the retro-orbital plexus under mild ether anesthesia and subjected for the estimation of markers of liver function such as SG PT, SGOT and serum alkaline phosphatases. Statistical Analysis:
The Individual values were expressed as Mean ± SEM. The results were analyzed statistically using One-Way ANOVA to find out the level of significance followed by Dunnet's post comparison test. The minimum level of significance was fixed at p<0.05. The analysis was carried out using GraphPad Prism version 4.01. The V ranges from 7 to 8 in each group.
Results:
The first study (Study-1) was carried out to evaluate and compare the hepatoprotective potential of different N P-042/ERN P variants (NP-042/ERNP-167, N P-042/ERNP-168, N P- 042/ERNP-169, NP-042/ERNP-170, NP-042/ERN P-171 and N P-042/ERN P-172) in a well established experimental model of carbon tetrachloride-induced hepatic damage in rats. The extracts were tested at equal dose but at multiple doses (14 days). For the purpose of testing and comparing, the dose of extracts was fixed at a dose of 500mg/kg/day p. o, The carbon tetrachloride-intoxicated rats showed severe and significant derangement in liver function markers like enzymes SGPT and SGOT levels. Treatment with N P- 042/ERN P-171 significantly reversed the elevation of serum markers of hepatic damage like, SGPT, SGOT levels in carbon tetrachloride-intoxicated rats at both the tested doses. There is also a appreciable decrease in the mean values of the serum markers of liver function in NP-042/ERNP-170, NP-042/ERNP-171 and N P-042/ERN P-168 treated groups. From the results of above experiments, it can be inferred that, different N P- 042/ERN P extracts offered a appreciable hepatoprotection in rats against the hepatic damage induced by well known hepatotoxin carbon tetrachloride but to a varying extent, at selected dose, mode of administration and in method employed.
In the second set of study (Study-2), the different N P-042 extracts (NP-042, NP-042A and N P-042A/123) were evaluated/ compared for their hepatoprotective potential in experimental model of thioacetamide-induced hepatotoxicity in rats. The N P-042 extracts were tested at single dose level of dose level of 1000 mg/kg body weight/ day for 15 days. The thioacetamide-intoxicated rats showed severe and significant derangement in liver function markers like enzymes SGPT, SGOT and serum alkaline phosphatase (ALP). Treatment with NP-042/A/123 and N P-042/A significantly reversed the elevation of specific serum markers of hepatic damage like, SGPT, SGOT levels in rats with hepatic damage. The reductions in liver markers were also found to be reduced in other extract treated group (NP-042).
In third set of study (Study-3), the extracts N P-042/A and N P-042/A/123 were compared for their hepatoprotective potential in a well-known experimental model of carbon tetrachloride-induced hepatotoxicity in rats. Both the extracts were tested at two dose levels (500mg and 1000 mg/kg/day p.o. ). The assigned treatments were carried out for 14 days prior to challenge with a hepatotoxin, carbon tetrachloride. The carbon tetrachloride-intoxicated rats showed severe and significant derangement in liver function markers like enzymes SGPT, SGOT and also serum alkaline phosphatase levels. Treatment with NP-042A/123 significantly reversed the elevation of serum markers of hepatic damage like, SGPT, SGOT levels in carbon tetrachloride-intoxicated rats at both the tested doses. There is also a decrease in the mean values of the liver marker levels in NP-042A treated groups.
The following methodologies, examples, and tables were adopted for the various formulation of the herbal composition which illustrates the present invention:
Example 34
Total chemical constituents of various herbal blend extracts
Samples were analysed for total andrographolides, total tannins, flavonoids and alkaloids by in house specification methods. Results are mentioned in Table-2.
Table-2
Figure imgf000029_0001
Example 35
Standarisation of extracts by LCMSMS method analysis
LC-MS/MS optimization conditions: The LC-MS/MS analysis performed with Shimadzu LC-20 AD Prominence series HPLC system. LC separation was performed on a Reverse phase C18 (250 X4.6mm, 5um) Phenomenex column. The mobile phase consisted of 0.1% acetic acid in water and acetonitrile in a ratio of 90:10 (v/v), delivered at a flow rate of lml/min. The autosamp!er SIL-HTC (Shimadzu maker) injection volume was set at 20μΙ. UV detector chromatograms were monitor at 275nm and 254nm.
The API-2000 (Applied Biosystems, Canada) tandem triple quadrupole mass spectrometer equipped with an ESI source coupled with LC separation system in positive mode was used to ionize the molecules. Analyst 1.5 version was used for the control of equipment, acquisition and data analysis. ESI source conditions as follows: declustering potential (DP) 10 V, source gas (GS1) 50 psi and (GS2) 60 psi, curtain gas (CUR) 20psi, ion spray voltage (IS) 5500 V, focusing potential (FP) 400 psi and source temperature (TEM) 428 C were optimized with respect to ionization intensity response of the peak.
Sample solution preparation:
Individual sample solutions were prepared in the concentration of lmg/ml by weighing accurately 10 mg of individual samples in a separate 10 ml clean volumetric flask. The aqueous extracts were dissolved in water and remaining solvent extracts were dissolved in methanol by sonication for 10 min in an ultrasonic bath and finally made up to the volume respectively. The final sample solutions were filtered through 0.2μιτι syringe filter before loading to the autosampler.
The major chemical constituents detected in various herbal blend extracts were identified as fumaramine, cichoriin, chlorogenic acid, lactupicrin, protopine, wedeloactone, luteolin, andrographolide etc.
The results are mentioned in below Table-3
Name of herb in Chemical constituents MW (m/z) formulation identified
Cichorium intybus Lactucin 276.28
8-deoxylactucin 260
Chlorogenic acid 354.31
Cichoriin 340.28
Lactupicrin 410.13
Iso-chlorogenic acid 516.45
Fumaria indica d-hydrastine 383.39
Protopine 353.36
Cryptopine 369.41 d-bicuculline 367.35
Fumaramine 380.39
Ailanthus excelsa Glaucarubin 496.23
3,4-dihydroexcelsin 480.59
Glaucarubinone 494.53
Glaucarubol 396.43
Glaucarubolone 394.41
Eclipta prostrata Wedelolactone 314.24
Nor-wedelolactone 300.21
Beta-amyrin 426.71
Hentriacontanol 452.83
Luteolin 286.23
Andrographis 14-deoxy-ll, 12- 332.0 paniculata dihydroandrographoli
de
Neoandrographolide 480.0 14- 496.0
deoxyandrographolide
Panicolin 314.0
Homo- 344.0
androgdrapholide
14-deoxy- 12- 350.0
hydroxyandrographoli
de
14-deoxy-l l- 348.0
oxoandrographolide
14- 334.0
deoxyandrographolide
3,14- 318.0
dihydroxyandrograph
olide
Andrographiside 512.0
Andrographin 328.0
Andrographane 562.0
Example 36
Pharmaceutical formulations details
Direct compression of tablets
Procedure: Herbal actives and excipients were sieved through a 36 mesh sieve, resulting blend was then compressed into tablets. The composition of the tablets was as follows
Table-4
S.No. Ingredients Formula 1 Formula 2 Formula 3 Formula 4
(in mg) (in mg) (in mg) (in mg)
1 N P-042 SPD Extract 450 450 450 450
2 M icrocrystalline 200 375 170 270 cellulose 102
3 Maize starch 170 45 - -
4 Croscarmellose 35 - 25 - sodium 5 Magnesium stearate 5 5 - -
6 Sodium starch - 25 - - glycolate
7 Lactose DC - - 250 -
8 Colloidal Silicon - - 5 5 Dioxide
9 Dicalcium phosphate - - - 250 Dihydrate
10 PVP K 30 - - - 25
Total 850 900 900 1000
Results:
Direct compression tablets parameters are mentioned
Table-5
Figure imgf000033_0001
Granulation: By using Purified Water as a granulating fluid
PROCEDURE: Active and excipients were sieved through a 36 mesh sieve into a suitable mixer and granulated with a suitable quantity of boiled cooled purified water to form a medium /heavy granule. The granules were dried in a suitable oven at 60°C, until the LOD was <2%. The granulation was also tried with Isopropyl alcohol, alcohol etc.
BLENDING: The resulting dried granule was then passed through a 16 mesh sieve to give a granule and then blended with excipients. The resulting blend was then compressed into tablets using suitable capsule shaped tooling to give capsule shaped tablet, The composition of the tablets are mentioned in Table-6. Table -6
Formula Formula Formula Formula Formula Formula
SI.
Ingredients 1 2 3 4 5 6 No.
(in mg) (in mg) (in mg) (in mg) (in mg) (in mg)
NP-042 SPD
1 450 450 450 450 450 450 Extract
Microcrystalline
2 250 300 - - 300 150 cellulose
3 Maize starch - - - - 130
Talc - 50 - - - -
Croscarmellose
4 30 - 25 - 20 27 sodium
Magnesium
5 aluminum - - - - - 200 silicate
Pregelatinized
6 - - 80 - - - Starch
7 Lactose - - - 150 - -
Sodium starch
8 - 30 - 30 - - glycolate
Dicalcium
9 Phosphate - - 325 350 - -
Dihydrate
10 Purified water Qs Qs Qs Qs Qs Qs
B lending
Croscarmellose 18
11 15 - 15 15 15
sodium
Magnesium 5
12 5 5 - - 5
stearate
Sodium starch -
13 - 15 - - - glycolate
Colloidal Silicon -
14 - - 5 5 - Dioxide
Total 750 850 900 1000 920 850 RESULT: Wet Granulation by using excipients and Purified water as a granulating fluid, Results are mentioned in Table-7
Table-7
Figure imgf000035_0001
Capsule Formulation: By using purified water as a granulating fluid.
PROCEDURE: Active and excipients were sieved through a 36 mesh sieve into a suitable mixer and granulated with a suitable quantity of boiled cooled purified water to form a medium /heavy granule. The granules were dried in a suitable oven at 60°C, until the LOD was <2%.
BLENDING: The resulting dried granule was then passed through a 16 mesh sieve to give a granule and then blended with excipients. The resulting blend was then filled in suitable size capsules, the final composition of the capsules are mentioned in Table-8
Table-8
Formula 1 Formula 2
S.No. Ingredients
(in mg) (in mg)
1 NP-042 SPD Extract 450 450
Microcrystalline
2 200 350
cellulose
3 Maize starch 200 - 4 Croscarmellose sodium 27 30
5 Purified Water Qs Qs
B lending
6 Croscarmellose sodium 18 -
7 Magnesium stearate 5 5
8 Sodium starch glycolate - 15
Total 900 850
RESULT: Granules were filled in size '00' capsules (Table-9)
Table-9
Figure imgf000036_0001
Although this invention has been described by example and with reference to possible embodiment thereof, it is to be understood that modifications or improvements may be made thereto without departing from the scope of the invention.

Claims

CLAIMS We claim:
1. A herbal composition having hepato-protective activity comprising effective amounts of extracts of Eclipta prostrata, Cichorium intybus, Androgrophis paniculata, Fumaria indica, Ailanthus excelsa and suitable pharmaceutically acceptable carriers and additives.
2. The herbal composition as claimed in claim 1, wherein the extracts are obtained either by separate extraction or from the blend of Eclipta prostrata, Cichorium intybus, Androgrophis paniculata, Fumaria indica, Ailanthus excelsa parts.
3. The herbal composition as claimed in claims 1 & 2, wherein the extracts are obtained from the specific parts of the herbs preferably whole parts of Eclipta prostrata, seeds of Cichorium intybus, whole parts of Androgrophis paniculata, whole parts of Fumaria indica and leaves of Ailanthus excelsa.
4. The herbal composition as claimed in claim 2 wherein the blend of herbs comprises whole parts of Eclipta prostrata, seeds of Cichorium intybus, whole parts of Androgrophis paniculata, whole parts of Fumaria indica and leaves of Ailanthus excelsa in the ratio of 20:18:30:15: 17 respectively.
5. A herbal composition having hepato-protective activity comprising effective amou nts of extracts of Eclipta prostrata, Cichorium intybus, Androgrophis paniculata, Fumaria indica, Oxoxylum indicum and suitable pharmaceutically acceptable carriers and additives.
6. The herbal composition as claimed in claim 5, wherein the extracts are obtained either by separate extraction or from the blend of Eclipta prostrata, Cichorium intybus, Androgrophis paniculata, Fumaria indica, Oxoxylum indicum parts.
7. The herbal composition as claimed in claims 5 & 6, wherein the extracts are obtained from the specific parts of the herbs preferably whole parts of Eclipta prostrata, seeds of Cichorium intybus, whole parts of Androgrophis paniculata, whole parts of Fumaria indica and leaves of Oxoxylum indicum.
8. The herbal composition as claimed in claim 6 wherein the blend of herbs comprises whole parts of Eclipta prostrata, seeds of Cichorium intybus, whole parts of Andrographis paniculata, whole parts of Fumaria indica and leaves of Oxoxylum indicum in the ratio of 20: 18:30: 15: 17 respectively.
9. The herbal composition as claimed in claims 1 & 5 wherein the preferable pharmaceutical carriers are Microcrystalline cellulose, Maize starch, Croscarmellose sodium, and mixtures thereof.
10. The herbal composition as claimed in claims 1 & 5 wherein the additives are in the form of blending agents, emulsifiers, preservatives, dispersants, and solvents known in the art.
11. The herbal composition as claimed in claims 1-7, wherein the said extracts are obtained by method selected from the group of percolation method, hot - soxlation method, super - critical - fluid method or enzyme extraction method .
12. The herbal composition as claimed in claims 1 - 7, wherein the said extracts are obtained by percolation method comprising the following steps of: a. Shade drying the material; b. Pulverizing the material obtained in step a. to coarse powder; c. Placing the powdered material in different percolators and extracting with n-hexane, acetone, ethyl alcohol, methanol, ethyl alcohol and water (1:1), methanol and water ( 1: 1) and water at room temperature for 24 h to 48 h; and d. Filtering the plant extracts and concentrating to dryness using a rotatory evaporator or on steam bath at optimum temperature under reduced pressure.
13. The herbal composition as claimed in claims 1 - 7, wherein the said extracts are obtained by hot-soxlation method comprising the steps of:
a. Placing the coarse powdered material in each soxlator using solvents n- hexane, acetone, ethyl alcohol, methanol, ethyl alcohol and water (1:1), methanol and water ( 1: 1) and water at refluxing temperature of each solvent;
b. recycling the process until extraction is completed; and
c. filtering the plant extracts and concentrating to dryness using rotatory evaporator or on steam bath at optimum temperature.
14. The herbal composition as claimed in claims 1 - 7, wherein the said extracts are obtained by super - critical - fluid extraction method comprising the steps of: a. Shade drying the material; b. Pulverizing the dried material to coarse powder; c. Placing the material in a SCF extractor at the temperature ranging from 40- 50 °C at high pressure range of 300-350 bar using carbon dioxide as super critical fluid for extraction upto 4 to 6 hours; and d. Collecting the extract in the collection vessel and evaporating at room temperature to remove any further residues of carbon dioxide.
15. The herbal composition as claimed in claims 1 - 7, wherein the said extracts are obtained by enzyme extraction method comprising the steps of: a. Shade drying the material; b. Pulverizing the dried material to coarse powder; c. Placing the material in Stainless Steel container and adding 0.5% to 5% of cellulase and pectinase enzyme combination in 4 volumes of distilled water; d. Processing the enzyme extraction at the temperature of 55°C to 60°C under occasional stirring upto 4-6 hours; and
e. Filtering the extract and concentrating the same to dryness on rotatory evaporator or on steam bath at optimum temperature under reduced pressure.
16. The herbal composition as claimed in claims 1 - 7, 11 and 15 wherein the yield from the enzyme extraction method is 8.99% for Eclipta prostrata, 12.45% for Cichorium intybus, 12.45% for Andrographis paniculata, 13.67% for Fumaria indica, 12.84% for Oxoxylum indicum, 13.5% for Ailanthus excelsa.
17. The herbal composition as claimed in claims 2, 4, 11 and 15 wherein the yield from the enzyme extraction method is 16.99% for herbal blend comprising Eclipta prostrata, Cichorium intybus, Andrographis paniculata, Fumaria indica and Ailanthus excelsa.
18. The herbal composition as claimed in claims 6, 8, 11 and 15 wherein the yield from the enzyme extraction method is 8.50% for herbal blend comprising Eclipta prostrata, Cichorium intybus, Andrographis paniculata, Fumaria indica and Oxoxylum indicum.
19. The herbal composition as claimed in claims 1 - 18 wherein the composition is in the form of a tablet, capsule, syrup, injection or any other suitable form.
PCT/IB2011/000002 2010-01-01 2011-01-01 A herbal composition as hepatoprotective and treatment for liver disorders WO2011080721A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN3/DEL/2010 2010-01-01
IN3DE2010 2010-01-01

Publications (2)

Publication Number Publication Date
WO2011080721A2 true WO2011080721A2 (en) 2011-07-07
WO2011080721A3 WO2011080721A3 (en) 2011-09-29

Family

ID=44226916

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2011/000002 WO2011080721A2 (en) 2010-01-01 2011-01-01 A herbal composition as hepatoprotective and treatment for liver disorders

Country Status (1)

Country Link
WO (1) WO2011080721A2 (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103142742A (en) * 2013-03-21 2013-06-12 河北康利动物药业有限公司 Method for preparing oral solution of poplar flower
CN104193758A (en) * 2014-08-27 2014-12-10 南京慧博生物科技有限公司 Method for preparing wedelolactone monomeric compounds extracted from eclipta
CN107129478A (en) * 2017-05-11 2017-09-05 延边大学 A kind of sesquiterpene lactone compounds and its preparation method and application
CN107434795A (en) * 2017-07-12 2017-12-05 延边大学 A kind of compound for preventing fatty liver and its preparation method and application
CN107519391A (en) * 2017-10-23 2017-12-29 重庆艾嘻百草生物科技有限公司 A kind of active wind-dispelling bath powder of toxin expelling excreting dampness
CN112939912A (en) * 2020-09-30 2021-06-11 石河子大学 Preparation method and application of lactucin extracted from cichorium intybus
CN113045520A (en) * 2021-03-25 2021-06-29 江西新世纪民星动物保健品有限公司 Extraction process of andrographolide
CN114957020A (en) * 2022-06-10 2022-08-30 贵州两山康瑞食品检测科技有限公司 Method for extracting and purifying choline from acer truncatum leaves
WO2023039105A1 (en) * 2021-09-08 2023-03-16 Karallief, Inc. Therapeutic herbal compositions for improving liver health

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6136316A (en) * 1996-04-17 2000-10-24 Dabur Research Foundation Hepatoprotective compositions and composition for treatment of conditions related to hepatitis B and E infection
US20050049206A1 (en) * 2003-09-01 2005-03-03 Gong Bang Qiang Compositions of flavonoids and flavonoid-containing extracts and the treatment of diseases
US20070135359A1 (en) * 2003-02-28 2007-06-14 Unigen Pharmaceuticals, Inc. Identification of Free-B-Ring Flavonoids as Potent COX-2 Inhibitors

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6136316A (en) * 1996-04-17 2000-10-24 Dabur Research Foundation Hepatoprotective compositions and composition for treatment of conditions related to hepatitis B and E infection
US20070135359A1 (en) * 2003-02-28 2007-06-14 Unigen Pharmaceuticals, Inc. Identification of Free-B-Ring Flavonoids as Potent COX-2 Inhibitors
US20050049206A1 (en) * 2003-09-01 2005-03-03 Gong Bang Qiang Compositions of flavonoids and flavonoid-containing extracts and the treatment of diseases

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
AHMED ET AL.: 'Antihepatoxic activity of seeds of Cichorium intybus' JOUMAL OF ETHNOPHARMACOLOGY vol. 87, 2003, pages 237 - 240 *
LAVHALE ET AL.: 'Nutritional and therapeutic potential of Ailanthus excelsa - A Review' PHARMACOGNOSY REVIEWS vol. 1, no. 1, 2007, pages 105 - 113 *
PRAMYOTHIN ET AL: 'Hepatoprotective activity of Eclipta prostrata LINN. extract in ethanol induced rat hepatic injury' J TRAD MED vol. 24, 2007, pages 164 - 167 *
RATHI ET AL.: 'Hepatoprotective potential of Fumaria indica Pugsley whole plant extracts, fractions and an isolated alkaloid protopine.' PHYTOMEDICINE vol. 15, 2008, pages 470 - 477 *

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103142742B (en) * 2013-03-21 2014-05-07 河北康利动物药业有限公司 Method for preparing oral solution of poplar flower
CN103142742A (en) * 2013-03-21 2013-06-12 河北康利动物药业有限公司 Method for preparing oral solution of poplar flower
CN104193758A (en) * 2014-08-27 2014-12-10 南京慧博生物科技有限公司 Method for preparing wedelolactone monomeric compounds extracted from eclipta
CN107129478B (en) * 2017-05-11 2021-10-26 延边大学 Semi-terpene lactone compound and preparation method and application thereof
CN107129478A (en) * 2017-05-11 2017-09-05 延边大学 A kind of sesquiterpene lactone compounds and its preparation method and application
CN107434795B (en) * 2017-07-12 2022-03-29 延边大学 Compound for preventing fatty liver and preparation method and application thereof
CN107434795A (en) * 2017-07-12 2017-12-05 延边大学 A kind of compound for preventing fatty liver and its preparation method and application
CN107519391A (en) * 2017-10-23 2017-12-29 重庆艾嘻百草生物科技有限公司 A kind of active wind-dispelling bath powder of toxin expelling excreting dampness
CN112939912A (en) * 2020-09-30 2021-06-11 石河子大学 Preparation method and application of lactucin extracted from cichorium intybus
CN113045520A (en) * 2021-03-25 2021-06-29 江西新世纪民星动物保健品有限公司 Extraction process of andrographolide
WO2023039105A1 (en) * 2021-09-08 2023-03-16 Karallief, Inc. Therapeutic herbal compositions for improving liver health
CN114957020A (en) * 2022-06-10 2022-08-30 贵州两山康瑞食品检测科技有限公司 Method for extracting and purifying choline from acer truncatum leaves
CN114957020B (en) * 2022-06-10 2024-03-08 贵州两山康瑞食品检测科技有限公司 Method for extracting and purifying choline from acer truncatum leaves

Also Published As

Publication number Publication date
WO2011080721A3 (en) 2011-09-29

Similar Documents

Publication Publication Date Title
WO2011080721A2 (en) A herbal composition as hepatoprotective and treatment for liver disorders
US20080113044A1 (en) Extracts and Methods Comprising Green Tea Species
KR20080038127A (en) Cynara scolymus extracts, the use thereof and formulations containing them
US6383526B1 (en) Process for the extraction of valerian root
US9173912B2 (en) Cistus extract containing enriched secondary plant ingredients
US20140302180A1 (en) Composition comprising chicory extract
Akin-Osanaiye et al. Characterization and antimicrobial screening of ethyl oleate isolated from Phyllanthus amarus (Schum and Thonn)
WO2011083398A2 (en) Herbal composition for diarrhoea
EA030607B1 (en) Process for making extracts of plants of the scrophulariaceae family of the genus picrorhiza and use thereof for prevention and treatment of diseases caused by dna viruses
EP1485114A2 (en) Isolation, purification and structural identification of a bioactive component of a water soluble extract of a botanical species for enhancing immune, anti-inflammatory, anti-tumor and dna repair processes of warm blooded animals
US20080138445A1 (en) Pharmaceutical mixture for Hepatitis treatment and its preparation method
Mishra et al. Andrographolide content in Madhya Pradesh, India
WO2011083397A1 (en) Herbal composition for skin disorders
WO2011080579A2 (en) A herbal composition for inflammatory disorders
US6395308B1 (en) Purified extract from Harpagophytum procumbens and/or Harpagophytum zeyheri dence
US20180228861A1 (en) Composition for treating diabetes and dyslipidemia obtained from the extract of costus pictus d.don plant and a method of preparing the same
US11541093B2 (en) Pharmacological use of Cimicifuga extract
Miranda-Martínez et al. Pharmacognostic, chemical and mucolytic activity study of Malva pseudolavatera Webb & Berthel. and Malva sylvestris L.(Malvaceae) leaf extracts, grown in Ecuador
Joanofarc et al. Evaluation of antidiarrhoeal activity of Aerva species
Stamenković et al. Optimization of HPLC method for the isolation of Hypericum perforatum L. methanol extract
KR20230023744A (en) Method for preparing an extract of a plant of the genus Epilobium with a high oenotein B content
KR100558930B1 (en) Purified extracts obtained from Harpagopitum procumbens and / or Harpagopitum J. heidens, preparation methods thereof and uses thereof
JP2004352680A (en) Composition for treatment of allergic disease
Dlamini Isolation and characterization of bio-active compounds from Lippia javanica
Babu et al. Hepatoprotective activity of Tridecan-1-ol isolatedfrom Flaveria trinervia (Speng). C. Mohr

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11728531

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase in:

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11728531

Country of ref document: EP

Kind code of ref document: A2